NEW YORK, NY / ACCESSWIRE / January 7, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Joyy Inc. (NASDAQ:YY)

CONTACT JAKUBOWITZ ABOUT YY:
https://claimyourloss.com/securities/joyy-inc-loss-submission-form/?id=12003&from=1

Class Period: April 28, 2016 - November 18, 2020

Lead Plaintiff Deadline : January 19, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) The majority of users at any given time were bots; (2) the Company utilized these bots to effect a roundtripping scheme that Manufactured the false appearance of revenues; (3) the Company overstated its cash reserves; (4) the Company's acquisition of Bigo was largely contrived to benefit corporate insiders; and (5) as a result, Defendants' public statements were materially false and/or Misleading at all relevant times.

Boston Scientific Corporation (NYSE:BSX)

CONTACT JAKUBOWITZ ABOUT BSX:
https://claimyourloss.com/securities/boston-scientific-corporation-loss-submission-form/?id=12003&from=1

Class Period: April 24, 2019 - November 16, 2020

Lead Plaintiff Deadline : February 2, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the LOTUS Edge Aortic Valve System's product delivery system was dysfunctional and threatened the continued viability of the entire product line; (ii) as a result, the Company had materially overstated the continued commercial viability and profitability of the LOTUS Edge Aortic Valve System; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Triterras, Inc., f/k/a Netfin Acquisition Corp. (NASDAQ:TRIT)

CONTACT JAKUBOWITZ ABOUT TRIT:
https://claimyourloss.com/securities/triterras-inc-f-k-a-netfin-acquisition-corp-loss-submission-form/?id=12003&from=1

Class Period: August 20, 2020 - December 16, 2020

Lead Plaintiff Deadline : February 19, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the extent to which Company's revenue growth relied on Triterras' relationship with Rhodium to refer users to the Kratos platform; (2) that Rhodium faced significant financial liabilities that jeopardized its ability to continue as a going concern; (3) that, as a result, Rhodium was likely to refer fewer users to the Company's Kratos platform; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law

View source version on accesswire.com:
https://www.accesswire.com/623498/Lawsuits-Filed-Against-YY-BSX-and-TRIT--Jakubowitz-Law-Pursues-Shareholders-Claims